SUMMARY The development of contrast ventriculography is outlined and an experience with 40 meglumine iothalamate ventriculograms in 37 patients is described. The details of the procedure, hazards, value, and indications are discussed.
Ventriculography was introduced as a neurosurgical diagnostic procedure in 1918 by Walter Dandy. Over the years it has proved to be a very useful technique indeed, especially in children (due to the thinness of the skull) and especially since the coronal route has become favoured in many neurosurgical centres.
At first air was used as a negative contrast medium and other gases have also been used. Sometimes large volumes of air must be introduced to obtain adequate pictures, altering the intraventricular pressures and irritating the ependyma, occasionally with disastrous results, and the patient has to be placed in various positions in order to demonstrate the entire ventricular system. In spite of this, there is sometimes difficulty in demonstrating the 3rd ventricle, aqueduct, and 4th ventricle adequately by this method.
A safe method of positive contrast ventriculography has long been sought. In 1928 Balado used Pantopaque ventriculography requires the services of a radiologist with a fluoroscopic screen or image amplification unit, and spot films must be taken during manipulation of the head.
To remedy some of these objections, PorteraSanchez, Bravo, and Parera (1964) introduced the use ofemulsified Pantopaque. In many neurosurgical units this did not prove to be a satisfactory method of ventriculography because of the vigorous shaking required, the short period of time in which the substance remained emulsified in the ventricles, and the speed with which the pictures had to be taken; nonetheless, still leaving the Pantopaque permanently, in many cases, in the ventricular system. In our hands, a febrile reaction is common with this technique. Heimburger, Kalsbeck, Campbell, and Healey (1966) published their work with meglumine iothalamate 60%1 as a water soluble ventriculographic medium. They first experimented with animals and subsequently expanded their studies to humans. The pictures obtained with this medium were quite good. Animal experimentation has shown that injections of this substance into the cisterna magna can cause convulsions or even death. Reports began to circulate among neurosurgeons that meglumine iothalamate ventriculography was not without its hazards in humans. However, other investigators reported that they had virtually no complications (Handa and Handa, 1969) .
Feeling that safe, water soluble, positive con- for which he was being treated. There was no evidence of ependymitis or other ill effect from the contrast medium. The other two are alive and apparently have not suffered ill effects from ventriculography. Four patients have had seizures. In one of these the contrast medium was injected into a subarachnoid 'puddle' by mistake and in another into the interhemispheric fissure. These cases taught us to check the needle position by radiography or fluoroscopy with air. One patient had agenesis of the corpus callosum and the effect was similar, probably because the meglumine iothalamate was not confined to an ependymalined cavity. The fourth patient was our first, mentioned above, in whom contrast medium escaped along the needle track to the cerebral cortex. He taught us to remove the contrast medium and to wait 20 minutes before withdrawing the needle.
Three patients, infants, had extensor spasms of the extremities which could be precipitated by sensory stimuli. In these patients contrast medium in large quantities passed out of the fora- 'Excessive doses of water soluble positive contrast media, injected into the cisterna magna or ventricle, were lethal' (Heimburger et al. 1966) . They reported a hydrocephalic child who died after receiving 10 ml. meglumine iothalamate intraventricularly.
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